Swipe om te navigeren naar een ander artikel
In light of the known associations between stress, negative affect, and relapse, mindfulness strategies hold promise as a means of reducing relapse susceptibility. In a pilot randomized clinical trial, we evaluated the effects of Mindfulness-Based Relapse Prevention (MBRP), relative to a health education control condition (HE) among stimulant-dependent adults receiving contingency management. All participants received a 12-week contingency management (CM) intervention. Following a 4-week CM-only lead in phase, participants were randomly assigned to concurrently receive MBRP (n = 31) or HE (n = 32). The primary outcomes were stimulant use, measured by urine drug screens weekly during the intervention and at 1 month post-treatment, negative affect, measured by the Beck Depression Inventory and Beck Anxiety Inventory, and psychiatric severity, measured by the Addiction Severity Index. Medium effect sizes favoring MBRP were observed for negative affect and overall psychiatric severity outcomes. Depression severity changed differentially over time as a function of group, with MBRP participants reporting greater reductions through follow-up (p = 0.03; effect size = 0.58). Likewise, the MBRP group evidenced greater declines in psychiatric severity (p = 0.01; effect size = 0.61 at follow-up). Among those with depressive and anxiety disorders, MBRP was associated with lower odds of stimulant use relative to the control condition (odds ratio (OR) = 0.78, p = 0.03 and OR = 0.68, p = 0.04). MBRP effectively reduces negative affect and psychiatric impairment, and is particularly effective in reducing stimulant use among stimulant-dependent adults with mood and anxiety disorders.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Beck, A. T. (1967). Depression: clinical, experimental, and theoretical aspects. New York: Harper and Row.
Beck, A. T., & Steer, R. A. (1990). Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation.
Bowen, S., Chawla, N., Collins, S., Witkiewitz, K., Hsu, S., & Grow, J. (2009). Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Substance Abuse, 30(4), 205–305. CrossRef
Bowen, S., Chawla, N., & Marlatt, G.A. (2011). Mindfulness-based relapse prevention for addictive behaviors: a clinician’s guide. Guilford Press.
Bowen, S., Witkiewitz, K., Clifasefi, S. L., Grow, J., Chawla, N., & Hsu, S. H. (2014). Relative Efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry, 71(5), 547–556. CrossRefPubMedPubMedCentral
Breslin, F. C., Zack, M., & McMain, S. (2002). An information-processing analysis of mindfulness: implications for relapse prevention in the treatment of substance abuse. Clinical Psychology: Science and Practice, 9(3), 275–299.
Chiessa, A., & Serretti, A. (2014). Are mindfulness-based interventions effective for substance use disorders? A systematic review of the evidence. Substance Use and Misuse, 49(5), 492–512. CrossRef
Garland, E. L., Gaylord, S. A., Boettiger, C. A., & Howard, M. O. (2010). Mindfulness training Modifies cognitive, affective, and physiological mechanisms implicated in alcohol dependence: results of a randomized, controlled pilot trial. Journal of Psychoactive Drugs, 42(2), 177–192. CrossRefPubMedPubMedCentral
Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Mooney, L.J., Rawson, R., & Methamphetamine Treatment Project Corporate Authors. (2009). Depression among methamphetamine users: association with outcomes from the methamphetamine treatment project at 3-year follow-up. Journal of Nervous and Mental Disease, 197(4), 225–231. CrossRef
Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment, 26, 41–54. CrossRef
Hoffman, S. G., Sawyer, A. T., & Oh, D. (2010). The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. Journal of Consulting and Clinical Psychology, 78(2), 169–183. CrossRef
Marlatt, G. A. (1996). Taxonomy of high-risk situations for alcohol relapse: evolution and development of a cognitive-behavioral model. Journal of Addiction, 91(Suppl), S37–S49. CrossRef
Marlatt, G. A., & Marques, J. K. (1977). Meditation, self-control, and alcohol use. In R. B. Stuart (Ed.), Behavioral self-management: strategies, techniques, and outcomes (pp. 117–153). New York: Brunner/Mazel.
Segal, Z. V., Bieling, P., Young, T., MacQueen, G., & Cooke, R. (2010). Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo for relapse prophylaxis in recurrent depression. Archives of General Psychiatry, 67(12), 1256–1264. CrossRefPubMedPubMedCentral
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, Suppl 20, 22–33.
Wegner, D. M., & Zanakos, S. (1994). Chronic thought suppression. Journal of Personality, 62, 615–640. CrossRef
Witkiewitz, K., Bowen, S., Harrop, E. N., Douglas, H., Enkema, M., & Sedgwick, C. (2014). Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change. Subst Use and Misuse, 49(5), 513–524. CrossRef
Witkiewitz, K., Marlatt, G. A., & Walker, D. (2005). Mindfulness-based relapse prevention for alcohol and substance use disorders. Journal of Cognitive Psychotherapy, 19(3), 211–228. CrossRef
- Mindfulness-Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial
Larissa J. Mooney
Hélène Chokron Garneau
Richard A. Rawson
- Springer US